Corbacioglu, S., & Greil, J. (2012). Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: An open-label, phase 3, randomised controlled trial. The lancet, 379(9823), . https://doi.org/10.1016/S0140-6736(11)61938-7
Chicago-Zitierstil (17. Ausg.)Corbacioglu, Selim, und Johann Greil. "Defibrotide for Prophylaxis of Hepatic Veno-occlusive Disease in Paediatric Haemopoietic Stem-cell Transplantation: An Open-label, Phase 3, Randomised Controlled Trial." The Lancet 379, no. 9823 (2012). https://doi.org/10.1016/S0140-6736(11)61938-7.
MLA-Zitierstil (9. Ausg.)Corbacioglu, Selim, und Johann Greil. "Defibrotide for Prophylaxis of Hepatic Veno-occlusive Disease in Paediatric Haemopoietic Stem-cell Transplantation: An Open-label, Phase 3, Randomised Controlled Trial." The Lancet, vol. 379, no. 9823, 2012, https://doi.org/10.1016/S0140-6736(11)61938-7.